본문으로 건너뛰기
← 뒤로

Supporting patients receiving oral systemic anti-cancer therapies.

PLoS medicine 2026 Vol.23(4) p. e1005022

Drury A, Fowler M, Richmond J

📝 환자 설명용 한 줄

Oral systemic anti-cancer therapies improve convenience, but also shift responsibility for treatment management to the patient.

이 논문을 인용하기

BibTeX ↓ RIS ↓
APA Drury A, Fowler M, Richmond J (2026). Supporting patients receiving oral systemic anti-cancer therapies.. PLoS medicine, 23(4), e1005022. https://doi.org/10.1371/journal.pmed.1005022
MLA Drury A, et al.. "Supporting patients receiving oral systemic anti-cancer therapies.." PLoS medicine, vol. 23, no. 4, 2026, pp. e1005022.
PMID 41920846

Abstract

Oral systemic anti-cancer therapies improve convenience, but also shift responsibility for treatment management to the patient. Education, communication, and models of care must adapt to support safe, equitable, and sustainable oral anti-cancer treatment.

MeSH Terms

Humans; Neoplasms; Antineoplastic Agents; Administration, Oral; Patient Education as Topic